Model Number CDS0701-XTW |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Dyspnea (1816); High Blood Pressure/ Hypertension (1908); Pleural Effusion (2010); Heart Failure/Congestive Heart Failure (4446); Tricuspid Valve Insufficiency/ Regurgitation (4453)
|
Event Date 05/17/2022 |
Event Type
Death
|
Event Description
|
This report is being conservatively filed due to worsening heart failure and patient death, unknown if device related.Patient id: (b)(6).It was reported that on (b)(6) 2021, the patient presented with degenerative mitral regurgitation with a posterior leaflet prolapse.Two mitraclips were implanted without a device issue, reducing the mr to grade 1+ and 2+.On (b)(6) 2022, the patient was hospitalized for heart failure with shortness of breath.A pleural effusion was noted, and medications were provided.The patient was discharged home with hospice due to end stage heart failure.On (b)(6) 2022, the patient expired.Per physician, the event is unknown if device related.No additional information was provided regarding this issue.
|
|
Manufacturer Narrative
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Manufacturer Narrative
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the reported heart failure appears to be due to worsening of existing patient condition.The reported dyspnea, pleural effusion, tricuspid regurgitation, hypertension, and death appear to be cascading events of the heart failure.Additionally, heart failure, dyspnea, hypertension, and death are listed in the instructions for use as known possible complications associated with mitraclip procedures.The reported hospitalization and medication were the results of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.B3: date of event updated.
|
|
Event Description
|
Subsequent to the previous report, the additional information was received: on 05/17/2022, during hospitalization for sepsis, worsening, severe tricuspid regurgitation was observed.On (b)(6) 2022, severe pulmonary hypertension was noted.Pulmonary artery pressure was up to 89mmhg.No treatment was provided.
|
|
Search Alerts/Recalls
|
|